+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Breast Biopsy Device Market - Global Forecast to 2030- Product Image
Breast Biopsy Device Market - Global Forecast to 2030- Product Image
Sale

Breast Biopsy Device Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011423
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Breast Biopsy Device Market grew from USD 1.10 billion in 2024 to USD 1.22 billion in 2025. It is expected to continue growing at a CAGR of 10.76%, reaching USD 2.03 billion by 2030.

The breast biopsy device market stands at a pivotal juncture as technological advances, shifting reimbursement frameworks, and evolving clinical guidelines converge to reshape diagnostic protocols. Recent years have seen accelerated adoption of minimally invasive techniques, driven by the imperative to improve patient comfort and procedural precision. Innovations in guidance systems-from MRI and ultrasound to emerging robotic assistance-are enhancing lesion targeting accuracy and reducing procedure times. Concurrently, providers and payers demand cost-effective solutions that deliver reliable histological outcomes while minimizing complications.

Amid rising breast cancer incidence globally, early and accurate diagnosis remains a top priority. Practitioners increasingly favor image-guided core needle and vacuum-assisted devices over open surgical approaches, reflecting both clinical efficacy and patient preference trends. Moreover, integration of artificial intelligence algorithms promises to elevate real-time lesion characterization, potentially streamlining biopsy pathways and optimizing resource allocation.

This report offers a rigorous overview of transformative trends, examines the implications of forthcoming U.S. tariffs, dissects market segmentation nuances, and delivers actionable insights for manufacturers, healthcare providers, and investors committed to advancing breast cancer diagnostics.

Transformative Shifts Reshaping the Breast Biopsy Device Landscape

The landscape of breast biopsy devices is undergoing transformative shifts as innovations and market forces realign priorities. First, the convergence of multimodal image guidance has blurred traditional boundaries: systems that once relied solely on stereotactic X-ray are now incorporating MRI and ultrasound capabilities to improve lesion visualization and targeting. Second, the emergence of robotic-assisted systems is set to redefine precision benchmarks, enabling sub-millimeter accuracy and real-time needle trajectory adjustments.

Meanwhile, patient-centric design has driven development of smaller, more ergonomic biopsy tables and disposable instrumentation, reducing cross-contamination risks and streamlining workflow in high-volume centers. On the regulatory front, updated clinical guidelines emphasize minimally invasive core needle techniques over open surgical biopsy, pressuring manufacturers to refine vacuum-assisted devices and fine needle aspiration tools. In tandem, providers are demanding integrated solutions that offer seamless interoperability with hospital imaging archives and electronic health records.

Collectively, these shifts underscore a transition from one-size-fits-all devices toward tailored platforms optimized for specific lesion types, procedural settings, and patient demographics. Organizations that anticipate these dynamics and invest strategically in R&D will lead the next wave of market leadership.

Assessing the Cumulative Impact of US Tariffs in 2025

As of 2025, newly imposed U.S. tariffs on surgical and diagnostic instruments are exerting upward pressure on import costs, prompting both domestic and international manufacturers to reassess supply chain strategies. Biopsy device providers that previously depended on low-cost offshore component sourcing have begun relocating assembly operations to North American facilities, mitigating tariff exposure while enhancing lead times. However, these shifts have led to short-term price adjustments that may influence hospital procurement budgets.

At the same time, providers are exploring alternative sourcing from regional partners in Europe and Asia-Pacific, seeking to diversify risk without sacrificing quality. Some vendors have negotiated tariff exemptions by qualifying under specific free-trade agreements or by reclassifying components within less-dutiable categories. Meanwhile, distributors and group purchasing organizations are leveraging collective bargaining power to absorb incremental duties and shield end users from abrupt cost pass-through.

In the long run, the tariff landscape is fueling strategic partnerships, joint ventures, and localized manufacturing hubs. Market participants that proactively address these policy shifts will preserve margin stability, maintain competitive pricing, and secure sustainable growth amid evolving trade regulations.

Key Insights Across Market Segmentation Dimensions

Diving into device type segmentation reveals that guidance systems-spanning mammography-guided, MRI-guided, and ultrasound-guided platforms-continue to garner significant investment, driven by the pursuit of higher diagnostic accuracy. Concurrently, breast biopsy tables are evolving into integrated workstations, enabling streamlined workflows across diagnostic centers. In parallel, needle-based instruments, including core needle, fine needle aspiration, and vacuum-assisted devices, are benefiting from material innovations that enhance tissue sampling efficiency while reducing patient discomfort.

On the technology front, image-guided solutions-bolstered by MRI, ultrasound, and X-ray modalities-dominate adoption, yet non-image-guided devices and robotic-assisted systems are carving out niche applications where cost or accessibility constraints prevail. Application segmentation underscores that procedures targeting palpable breast lumps, microcalcifications, and suspicious lesions each demand tailored device attributes-from needle gauge to guidance precision.

End users, ranging from ambulatory surgical centers to diagnostic imaging facilities and hospital settings, exhibit distinct procurement priorities: ambulatory centers emphasize throughput, diagnostic centers value modality flexibility, and hospitals prioritize integration with existing imaging infrastructure. Further refinement emerges through guidance system specialization-MRI, stereotactic, and ultrasound-while procedural choices between closed (core and fine needle) and open biopsy influence device selection. Finally, disposable versus reusable instrument strategies reflect a balance between infection control imperatives and total cost of ownership. These segmentation insights equip stakeholders to align product portfolios with evolving clinical and economic requirements.

Regional Market Dynamics and Growth Drivers

Regional analysis indicates that the Americas maintain a strong position in device innovation and clinical adoption, underpinned by established reimbursement frameworks and high breast cancer screening rates. Leading vendors continue to introduce next-generation guidance systems and AI-driven adjuncts, reinforcing North American market leadership. In contrast, Europe, the Middle East & Africa presents a fragmented landscape: Western Europe’s mature healthcare infrastructure supports early adoption of advanced biopsy tables and image-guided solutions, while EMEA’s emerging markets prioritize cost-effective portable devices and disposable instrumentation to expand access.

Meanwhile, Asia-Pacific is experiencing rapid growth fueled by rising healthcare expenditures, government screening initiatives, and expanding hospital networks. Local manufacturers in the region are forging strategic alliances with global players to localize production and adapt designs for varied procedural settings. Collectively, these regional dynamics underscore the importance of tailored go-to-market strategies, distribution partnerships, and price positioning to capture market share across diverse healthcare ecosystems.

Strategic Landscape of Leading Industry Players

The competitive landscape features a diverse mix of multinational conglomerates and specialized niche players. Advin Health Care and Argon Medical Devices, Inc. are distinguished by their core needle and fine needle portfolios, while Becton, Dickinson and Company and Cook Group Incorporated leverage broad medical device expertise to offer integrated biopsy solutions. Danaher Corporation and GE HealthCare Technologies Inc. drive innovation in image-guided systems, complemented by FUJIFILM Corporation’s strength in digital mammography and MRI guidance.

Leading players such as Hologic, Inc. and Siemens Healthcare GmbH continue to expand robotic-assisted and stereotactic capabilities, whereas Medtronic PLC and Merit Medical Systems, Inc. focus on vacuum-assisted platforms. Emerging competitors including Ningbo Xinwell Medical Technology Co., LTD. and Point Blank Medical emphasize cost-sensitive devices for ambulatory settings. Specialty firms like INRAD Inc., PAJUNK GmbH, and STERYLAB S.r.l. differentiate through customized disposables and reusable instrument sets.

Strategic moves-mergers, acquisitions, and R&D partnerships-are reshaping market share. For example, Thermo Fisher Scientific Inc.’s investment in biopsy consumables and Halma plc’s emphasis on infection control align with overarching clinical and regulatory trends. Together, these companies define the market’s innovation trajectory and competitive benchmarks.

Actionable Recommendations for Industry Leaders

To navigate this dynamic market, industry leaders should accelerate development of integrated image-guided platforms that combine MRI, ultrasound, and AI-powered lesion analysis. Forming strategic alliances with clinical research institutions can validate new robotic-assisted systems and ensure rapid clinical adoption. Simultaneously, manufacturers must diversify supply chains to mitigate tariff impacts, exploring localized assembly or duty-free trade zones.

Enhancing the total cost of ownership proposition by optimizing reusable and disposable instrument mixes will drive customer loyalty. Offering modular tables that support multiple guidance modalities can attract diagnostic centers seeking workflow flexibility. In emerging regions, tiered product offerings calibrated to local reimbursement realities will unlock growth opportunities.

Finally, investing in data analytics services and remote support platforms can differentiate offerings, enabling real-time maintenance and outcome tracking. By prioritizing these initiatives, companies can strengthen their competitive positioning, meet evolving provider needs, and deliver superior patient outcomes.

Conclusion: Navigating Future Opportunities

As the breast biopsy device market evolves, stakeholders who anticipate policy shifts, embrace technological convergence, and tailor strategies to segmented clinical needs will define future success. The transition toward minimally invasive, image-driven procedures underscores the importance of versatile platforms that can adapt across lesion types, procedural settings, and regional healthcare infrastructures. Companies that invest in supply chain resilience, strategic partnerships, and data-driven service models will enhance value propositions and capture leadership positions.

By synthesizing insights across device type, technology, application, end user, guidance system, procedure, and disposal status, this analysis offers a holistic view of market opportunities. The interplay between rising demand for diagnostic accuracy, tariff-driven cost dynamics, and regional growth vectors highlights the need for agile, patient-centric innovation. As competition intensifies, the ability to deliver integrated solutions that improve clinical workflows, reduce total cost of care, and support evidence-based decision-making will underpin sustainable growth.

Market Segmentation & Coverage

This research report categorizes the Breast Biopsy Device Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Biopsy Guidance Systems
    • Mammography-Guided Systems
    • MRI-Guided Systems
    • Ultrasound-Guided Systems
  • Breast Biopsy Tables
  • Needle-Based Biopsy Instruments
    • Core Needle Biopsy Devices
    • Fine Needle Aspiration Biopsy Devices
    • Vacuum-Assisted Biopsy Devices
  • Image-Guided Technology
    • MRI Technology
    • Ultrasound Technology
    • X-Ray Technology
  • Non-Image Guided Technology
  • Robotic-Assisted Systems
  • Breast Lump Biopsy
  • Microcalcification Biopsy
  • Suspicious Lesion Biopsy
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Hospitals
  • MRI Biopsy Systems
  • Stereotactic Biopsy Systems
  • Ultrasound Biopsy Systems
  • Closed Biopsy
    • Core Needle Biopsy
    • Fine Needle Aspiration
  • Open Biopsy
  • Disposable Devices
  • Reusable Devices

This research report categorizes the Breast Biopsy Device Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Breast Biopsy Device Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Advin Health Care
  • Argon Medical Devices, Inc.
  • Becton, Dickinson and Company
  • Cook Group Incorporated
  • Danaher Corporation
  • FUJIFILM Corporation
  • GE HealthCare Technologies Inc.
  • Halma plc
  • Hologic, Inc
  • INRAD Inc.
  • Medline Industries, LP
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Ningbo Xinwell Medical Technology Co., LTD.
  • PAJUNK GmbH
  • Planmeca Oy
  • Point Blank Medical
  • Siemens Healthcare GmbH
  • SNVL Varay Laborix
  • STERYLAB S.r.l.
  • Suretech Medical Inc.
  • Thermo Fisher Scientific Inc.
  • Trivitron Healthcare
  • Vector Medical, Inc.
  • Zamar Care

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Breast Biopsy Device Market, by Device Type
8.1. Introduction
8.2. Biopsy Guidance Systems
8.2.1. Mammography-Guided Systems
8.2.2. MRI-Guided Systems
8.2.3. Ultrasound-Guided Systems
8.3. Breast Biopsy Tables
8.4. Needle-Based Biopsy Instruments
8.4.1. Core Needle Biopsy Devices
8.4.2. Fine Needle Aspiration Biopsy Devices
8.4.3. Vacuum-Assisted Biopsy Devices
9. Breast Biopsy Device Market, by Technology
9.1. Introduction
9.2. Image-Guided Technology
9.2.1. MRI Technology
9.2.2. Ultrasound Technology
9.2.3. X-Ray Technology
9.3. Non-Image Guided Technology
9.4. Robotic-Assisted Systems
10. Breast Biopsy Device Market, by Application
10.1. Introduction
10.2. Breast Lump Biopsy
10.3. Microcalcification Biopsy
10.4. Suspicious Lesion Biopsy
11. Breast Biopsy Device Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Diagnostic Centers
11.4. Hospitals
12. Breast Biopsy Device Market, by Guidance System
12.1. Introduction
12.2. MRI Biopsy Systems
12.3. Stereotactic Biopsy Systems
12.4. Ultrasound Biopsy Systems
13. Breast Biopsy Device Market, by Procedure
13.1. Introduction
13.2. Closed Biopsy
13.2.1. Core Needle Biopsy
13.2.2. Fine Needle Aspiration
13.3. Open Biopsy
14. Breast Biopsy Device Market, by Reusable and Disposable Status
14.1. Introduction
14.2. Disposable Devices
14.3. Reusable Devices
15. Americas Breast Biopsy Device Market
15.1. Introduction
15.2. Argentina
15.3. Brazil
15.4. Canada
15.5. Mexico
15.6. United States
16. Asia-Pacific Breast Biopsy Device Market
16.1. Introduction
16.2. Australia
16.3. China
16.4. India
16.5. Indonesia
16.6. Japan
16.7. Malaysia
16.8. Philippines
16.9. Singapore
16.10. South Korea
16.11. Taiwan
16.12. Thailand
16.13. Vietnam
17. Europe, Middle East & Africa Breast Biopsy Device Market
17.1. Introduction
17.2. Denmark
17.3. Egypt
17.4. Finland
17.5. France
17.6. Germany
17.7. Israel
17.8. Italy
17.9. Netherlands
17.10. Nigeria
17.11. Norway
17.12. Poland
17.13. Qatar
17.14. Russia
17.15. Saudi Arabia
17.16. South Africa
17.17. Spain
17.18. Sweden
17.19. Switzerland
17.20. Turkey
17.21. United Arab Emirates
17.22. United Kingdom
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Advin Health Care
18.3.2. Argon Medical Devices, Inc.
18.3.3. Becton, Dickinson and Company
18.3.4. Cook Group Incorporated
18.3.5. Danaher Corporation
18.3.6. FUJIFILM Corporation
18.3.7. GE HealthCare Technologies Inc.
18.3.8. Halma plc
18.3.9. Hologic, Inc
18.3.10. INRAD Inc.
18.3.11. Medline Industries, LP
18.3.12. Medtronic PLC
18.3.13. Merit Medical Systems, Inc.
18.3.14. Ningbo Xinwell Medical Technology Co., LTD.
18.3.15. PAJUNK GmbH
18.3.16. Planmeca Oy
18.3.17. Point Blank Medical
18.3.18. Siemens Healthcare GmbH
18.3.19. SNVL Varay Laborix
18.3.20. STERYLAB S.r.l.
18.3.21. Suretech Medical Inc.
18.3.22. Thermo Fisher Scientific Inc.
18.3.23. Trivitron Healthcare
18.3.24. Vector Medical, Inc.
18.3.25. Zamar Care
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. BREAST BIOPSY DEVICE MARKET MULTI-CURRENCY
FIGURE 2. BREAST BIOPSY DEVICE MARKET MULTI-LANGUAGE
FIGURE 3. BREAST BIOPSY DEVICE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE SYSTEM, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE SYSTEM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY REUSABLE AND DISPOSABLE STATUS, 2024 VS 2030 (%)
FIGURE 20. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY REUSABLE AND DISPOSABLE STATUS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. BREAST BIOPSY DEVICE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. BREAST BIOPSY DEVICE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BREAST BIOPSY DEVICE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY MAMMOGRAPHY-GUIDED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY MRI-GUIDED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY ULTRASOUND-GUIDED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY BREAST BIOPSY TABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY FINE NEEDLE ASPIRATION BIOPSY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY VACUUM-ASSISTED BIOPSY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY IMAGE-GUIDED TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY MRI TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY ULTRASOUND TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY X-RAY TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY IMAGE-GUIDED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY NON-IMAGE GUIDED TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY ROBOTIC-ASSISTED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY BREAST LUMP BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY MICROCALCIFICATION BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY SUSPICIOUS LESION BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY MRI BIOPSY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY STEREOTACTIC BIOPSY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY ULTRASOUND BIOPSY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY CLOSED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY CORE NEEDLE BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY FINE NEEDLE ASPIRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY CLOSED BIOPSY, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY OPEN BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY REUSABLE AND DISPOSABLE STATUS, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY DISPOSABLE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY REUSABLE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY IMAGE-GUIDED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY CLOSED BIOPSY, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY REUSABLE AND DISPOSABLE STATUS, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA BREAST BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA BREAST BIOPSY DEVICE MARKET SIZE, BY IMAGE-GUIDED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA BREAST BIOPSY DEVICE MARKET SIZE, BY CLOSED BIOPSY, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA BREAST BIOPSY DEVICE MARKET SIZE, BY REUSABLE AND DISPOSABLE STATUS, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL BREAST BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL BREAST BIOPSY DEVICE MARKET SIZE, BY IMAGE-GUIDED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL BREAST BIOPSY DEVICE MARKET SIZE, BY CLOSED BIOPSY, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL BREAST BIOPSY DEVICE MARKET SIZE, BY REUSABLE AND DISPOSABLE STATUS, 2018-2030 (USD MILLION)
TABLE 81. CANADA BREAST BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 82. CANADA BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 83. CANADA BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 84. CANADA BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 85. CANADA BREAST BIOPSY DEVICE MARKET SIZE, BY IMAGE-GUIDED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 86. CANADA BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. CANADA BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. CANADA BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2030 (USD MILLION)
TABLE 89. CANADA BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 90. CANADA BREAST BIOPSY DEVICE MARKET SIZE, BY CLOSED BIOPSY, 2018-2030 (USD MILLION)
TABLE 91. CANADA BREAST BIOPSY DEVICE MARKET SIZE, BY REUSABLE AND DISPOSABLE STATUS, 2018-2030 (USD MILLION)
TABLE 92. MEXICO BREAST BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 93. MEXICO BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 94. MEXICO BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 95. MEXICO BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 96. MEXICO BREAST BIOPSY DEVICE MARKET SIZE, BY IMAGE-GUIDED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 97. MEXICO BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. MEXICO BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. MEXICO BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2030 (USD MILLION)
TABLE 100. MEXICO BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 101. MEXICO BREAST BIOPSY DEVICE MARKET SIZE, BY CLOSED BIOPSY, 2018-2030 (USD MILLION)
TABLE 102. MEXICO BREAST BIOPSY DEVICE MARKET SIZE, BY REUSABLE AND DISPOSABLE STATUS, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY IMAGE-GUIDED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY CLOSED BIOPSY, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY REUSABLE AND DISPOSABLE STATUS, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 115. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 116. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 117. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 118. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 119. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY IMAGE-GUIDED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 120. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2030 (USD MILLION)
TABLE 123. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 124. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY CLOSED BIOPSY, 2018-2030 (USD MILLION)
TABLE 125. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY REUSABLE AND DISPOSABLE STATUS, 2018-2030 (USD MILLION)
TABLE 126. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 127. AUSTRALIA BREAST BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 128. AUSTRALIA BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 129. AUSTRALIA BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 130. AUSTRALIA BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. AUSTRALIA BREAST BIOPSY DEVICE MARKET SIZE, BY IMAGE-GUIDED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 132. AUSTRALIA BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. AUSTRALIA BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. AUSTRALIA BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2030 (USD MILLION)
TABLE 135. AUSTRALIA BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 136. AUSTRALIA BREAST BIOPSY DEVICE MARKET SIZE, BY CLOSED BIOPSY, 2018-2030 (USD MILLION)
TABLE 137. AUSTRALIA BREAST BIOPSY DEVICE MARKET SIZE, BY REUSABLE AND DISPOSABLE STATUS, 2018-2030 (USD MILLION)
TABLE 138. CHINA BREAST BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 139. CHINA BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 140. CHINA BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 141. CHINA BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 142. CHINA BREAST BIOPSY DEVICE MARKET SIZE, BY IMAGE-GUIDED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 143. CHINA BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. CHINA BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. CHINA BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2030 (USD MILLION)
TABLE 146. CHINA BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 147. CHINA BREAST BIOPSY DEVICE MARKET SIZE, BY CLOSED BIOPSY, 2018-2030 (USD MILLION)
TABLE 148. CHINA BREAST BIOPSY DEVICE MARKET SIZE, BY REUSABLE AND DISPOSABLE STATUS, 2018-2030 (USD MILLION)
TABLE 149. INDIA BREAST BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 150. INDIA BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 151. INDIA BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 152. INDIA BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 153. INDIA BREAST BIOPSY DEVICE MARKET SIZE, BY IMAGE-GUIDED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 154. INDIA BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. INDIA BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. INDIA BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2030 (USD MILLION)
TABLE 157. INDIA BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 158. INDIA BREAST BIOPSY DEVICE MARKET SIZE, BY CLOSED BIOPSY, 2018-2030 (USD MILLION)
TABLE 159. INDIA BREAST BIOPSY DEVICE MARKET SIZE, BY REUSABLE AND DISPOSABLE STATUS, 2018-2030 (USD MILLION)
TABLE 160. INDONESIA BREAST BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 161. INDONESIA BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 162. INDONESIA BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 163. INDONESIA BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 164. INDONESIA BREAST BIOPSY DEVICE MARKET SIZE, BY IMAGE-GUIDED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 165. INDONESIA BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. INDONESIA BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. INDONESIA BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2030 (USD MILLION)
TABLE 168. INDONESIA BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 169. INDONESIA BREAST BIOPSY DEVICE MARKET SIZE, BY CLOSED BIOPSY, 2018-2030 (USD MILLION)
TABLE 170. INDONESIA BREAST BIOPSY DEVICE MARKET SIZE, BY REUSABLE AND DISPOSABLE STATUS, 2018-2030 (USD MILLION)
TABLE 171. JAPAN BREAST BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 172. JAPAN BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 173. JAPAN BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 174. JAPAN BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 175. JAPAN BREAST BIOPSY DEVICE MARKET SIZE, BY IMAGE-GUIDED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 176. JAPAN BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. JAPAN BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. JAPAN BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2030 (USD MILLION)
TABLE 179. JAPAN BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 180. JAPAN BREAST BIOPSY DEVICE MARKET SIZE, BY CLOSED BIOPSY, 2018-2030 (USD MILLION)
TABLE 181. JAPAN BREAST BIOPSY DEVICE MARKET SIZE, BY REUSABLE AND DISPOSABLE STATUS, 2018-2030 (USD MILLION)
TABLE 182. MALAYSIA BREAST BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 183. MALAYSIA BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 184. MALAYSIA BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 185. MALAYSIA BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 186. MALAYSIA BREAST BIOPSY DEVICE MARKET SIZE, BY IMAGE-GUIDED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 187. MALAYSIA BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. MALAYSIA BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. MALAYSIA BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2030 (USD MILLION)
TABLE 190. MALAYSIA BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 191. MALAYSIA BREAST BIOPSY DEVICE MARKET SIZE, BY CLOSED BIOPSY, 2018-2030 (USD MILLION)
TABLE 192. MALAYSIA BREAST BIOPSY DEVICE MARKET SIZE, BY REUSABLE AND DISPOSABLE STATUS, 2018-2030 (USD MILLION)
TABLE 193. PHILIPPINES BREAST BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 194. PHILIPPINES BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 195. PHILIPPINES BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 196. PHILIPPINES BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 197. PHILIPPINES BREAST BIOPSY DEVICE MARKET SIZE, BY IMAGE-GUIDED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 198. PHILIPPINES BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. PHILIPPINES BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. PHILIPPINES BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2030 (USD MILLION)
TABLE 201. PHILIPPINES BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 202. PHILIPPINES BREAST BIOPSY DEVICE MARKET SIZE, BY CLOSED BIOPSY, 2018-2030 (USD MILLION)
TABLE 203. PHILIPPINES BREAST BIOPSY DEVICE MARKET SIZE, BY REUSABLE AND DISPOSABLE STATUS, 2018-2030 (USD MILLION)
TABLE 204. SINGAPORE BREAST BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 205. SINGAPORE BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 206. SINGAPORE BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 207. SINGAPORE BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 208. SINGAPORE BREAST BIOPSY DEVICE MARKET SIZE, BY IMAGE-GUIDED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 209. SINGAPORE BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. SINGAPORE BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. SINGAPORE BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2030 (USD MILLION)
TABLE 212. SINGAPORE BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 213. SINGAPORE BREAST BIOPSY DEVICE MARKET SIZE, BY CLOSED BIOPSY, 2018-2030 (USD MILLION)
TABLE 214. SINGAPORE BREAST BIOPSY DEVICE MARKET SIZE, BY REUSABLE AND DISPOSABLE STATUS, 2018-2030 (USD MILLION)
TABLE 215. SOUTH KOREA BREAST BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 216. SOUTH KOREA BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 217. SOUTH KOREA BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 218. SOUTH KOREA BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 219. SOUTH KOREA BREAST BIOPSY DEVICE MARKET SIZE, BY IMAGE-GUIDED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 220. SOUTH KOREA BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. SOUTH KOREA BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. SOUTH KOREA BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2030 (USD MILLION)
TABLE 223. SOUTH KOREA BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 224. SOUTH KOREA BREAST BIOPSY DEVICE MARKET SIZE, BY CLOSED BIOPSY, 2018-2030 (USD MILLION)
TABLE 225. SOUTH KOREA BREAST BIOPSY DEVICE MARKET SIZE, BY REUSABLE AND DISPOSABLE STATUS, 2018-2030 (USD MILLION)
TABLE 226. TAIWAN BREAST BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 227. TAIWAN BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 228. TAIWAN BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 229. TAIWAN BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 230. TAIWAN BREAST BIOPSY DEVICE MARKET SIZE, BY IMAGE-GUIDED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 231. TAIWAN BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. TAIWAN BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. TAIWAN BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2030 (USD MILLION)
TABLE 234. TAIWAN BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 235. TAIWAN BREAST BIOPSY DEVICE MARKET SIZE, BY CLOSED BIOPSY, 2018-2030 (USD MILLION)
TABLE 236. TAIWAN BREAST BIOPSY DEVICE MARKET SIZE, BY REUSABLE AND DISPOSABLE STATUS, 2018-2030 (USD MILLION)
TABLE 237. THAILAND BREAST BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 238. THAILAND BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 239. THAILAND BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 240. THAILAND BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 241. THAILAND BREAST BIOPSY DEVICE MARKET SIZE, BY IMAGE-GUIDED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 242. THAILAND BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. THAILAND BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 244. THAILAND BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2030 (USD MILLION)
TABLE 245. THAILAND BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 246. THAILAND BREAST BIOPSY DEVICE MARKET SIZE, BY CLOSED BIOPSY, 2018-2030 (USD MILLION)
TABLE 247. THAILAND BREAST BIOPSY DEVICE MARKET SIZE, BY REUSABLE AND DISPOSABLE STATUS, 2018-2030 (USD MILLION)
TABLE 248. VIETNAM BREAST BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 249. VIETNAM BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 250. VIETNAM BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 251. VIETNAM BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 252. VIETNAM BREAST BIOPSY DEVICE MARKET SIZE, BY IMAGE-GUIDED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 253. VIETNAM BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. VIETNAM BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. VIETNAM BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2030 (USD MILLION)
TABLE 256. VIETNAM BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 257. VIETNAM BREAST BIOPSY DEVICE MARKET SIZE, BY CLOSED BIOPSY, 2018-2030 (USD MILLION)
TABLE 258. VIETNAM BREAST BIOPSY DEVICE MARKET SIZE, BY REUSABLE AND DISPOSABLE STATUS, 2018-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY IMAGE-GUIDED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY CLOSED BIOPSY, 2018-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY REUSABLE AND DISPOSABLE STATUS, 2018-2030 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 271. DENMARK BREAST BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 272. DENMARK BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 273. DENMARK BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 274. DENMARK BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 275. DENMARK BREAST BIOPSY DEVICE MARKET SIZE, BY IMAGE-GUIDED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 276. DENMARK BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 277. DENMARK BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 278. DENMARK BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2030 (USD MILLION)
TABLE 279. DENMARK BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 280. DENMARK BREAST BIOPSY DEVICE MARKET SIZE, BY CLOSED BIOPSY, 2018-2030 (USD MILLION)
TABLE 281. DENMARK BREAST BIOPSY DEVICE MARKET SIZE, BY REUSABLE AND DISPOSABLE STATUS, 2018-2030 (USD MILLION)
TABLE 282. EGYPT BREAST BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 283. EGYPT BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 284. EGYPT BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 285. EGYPT BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 286. EGYPT BREAST BIOPSY DEVICE MARKET SIZE, BY IMAGE-GUIDED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 287. EGYPT BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 288. EGYPT BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 289. EGYPT BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2030 (USD MILLION)
TABLE 290. EGYPT BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 291. EGYPT BREAST BIOPSY DEVICE MARKET SIZE, BY CLOSED BIOPSY, 2018-2030 (USD MILLION)
TABLE 292. EGYPT BREAST BIOPSY DEVICE MARKET SIZE, BY REUSABLE AND DISPOSABLE STATUS, 2018-2030 (USD MILLION)
TABLE 293. FINLAND BREAST BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 294. FINLAND BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 295. FINLAND BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 296. FINLAND BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 297. FINLAND BREAST BIOPSY DEVICE MARKET SIZE, BY IMAGE-GUIDED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 298. FINLAND BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 299. FINLAND BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. FINLAND BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2030 (USD MILLION)
TABLE 301. FINLAND BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 302. FINLAND BREAST BIOPSY DEVICE MARKET SIZE, BY CLOSED BIOPSY, 2018-2030 (USD MILLION)
TABLE 303. FINLAND BREAST BIOPSY DEVICE MARKET SIZE, BY REUSABLE AND DISPOSABLE STATUS, 2018-2030 (USD MILLION)
TABLE 304. FRANCE BREAST BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 305. FRANCE BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 306. FRANCE BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 307. FRANCE BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 308. FRANCE BREAST BIOPSY DEVICE MARKET SIZE, BY IMAGE-GUIDED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 309. FRANCE BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 310. FRANCE BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 311. FRANCE BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2030 (USD MILLION)
TABLE 312. FRANCE BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 313. FRANCE BREAST BIOPSY DEVICE MARKET SIZE, BY CLOSED BIOPSY, 2018-2030 (USD MILLION)
TABLE 314. FRANCE BREAST BIOPSY DEVICE MARKET SIZE, BY REUSABLE AND DISPOSABLE STATUS, 2018-2030 (USD MILLION)
TABLE 315. GERMANY BREAST BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 316. GERMANY BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 317. GERMANY BREAST BIOPSY DEVICE MARKET SIZE, BY NEEDLE-BASED BIOPSY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 318. GERMANY BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 319. GERMANY BREAST BIOPSY DEVICE MARKET SIZE, BY IMAGE-GUIDED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 320. GERMANY BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 321. GERMANY BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 322. GERMANY BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE SYSTEM, 2018-2030 (USD MILLION)
TABLE 323. GERMANY BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 324. GERMANY BREAST BIOPSY DEVICE MARKET SIZE, BY CLOSED BIOPSY, 2018-2030 (USD MILLION)
TABLE 325. GERMANY BREAST BIOPSY DEVICE MARKET SIZE, BY REUSABLE AND DISPOSABLE STATUS, 2018-2030 (USD MILLION)
TABLE 326. ISRAEL BREAST BIOPSY DEVICE MARKET SIZE, BY DEVICE

Companies Mentioned

  • Advin Health Care
  • Argon Medical Devices, Inc.
  • Becton, Dickinson and Company
  • Cook Group Incorporated
  • Danaher Corporation
  • FUJIFILM Corporation
  • GE HealthCare Technologies Inc.
  • Halma plc
  • Hologic, Inc
  • INRAD Inc.
  • Medline Industries, LP
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Ningbo Xinwell Medical Technology Co., LTD.
  • PAJUNK GmbH
  • Planmeca Oy
  • Point Blank Medical
  • Siemens Healthcare GmbH
  • SNVL Varay Laborix
  • STERYLAB S.r.l.
  • Suretech Medical Inc.
  • Thermo Fisher Scientific Inc.
  • Trivitron Healthcare
  • Vector Medical, Inc.
  • Zamar Care

Methodology

Loading
LOADING...

Related Topics

Related Reports

Biopsy Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Biopsy Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Biopsy Devices Market Report by Procedure Type, Product, Application, Guidance Technique, End User, and Region 2025-2033 - Product Image

Biopsy Devices Market Report by Procedure Type, Product, Application, Guidance Technique, End User, and Region 2025-2033

  • Report
  • 141 Pages
  • Global
From
Breast Biopsy Devices - Global Strategic Business Report - Product Image

Breast Biopsy Devices - Global Strategic Business Report

  • Report
  • 112 Pages
  • Global
From
Breast Biopsy Devices Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F - Product Image

Breast Biopsy Devices Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F

  • Report
  • 182 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.